US4737493AExpiredUtility
7-((substituted)amino)-8-((substituted)carbonyl)-methylamino)-1-oxaspiro(4,5)decanes as analgesic agents
Est. expiryJul 1, 2005(expired)· nominal 20-yr term from priority
Inventors:David C. Horwell
C07D 405/12C07D 409/12A61P 25/04C07D 307/94
89
PatentIndex Score
27
Cited by
7
References
30
Claims
Abstract
Substituted phenoxy-, 1-, and 2-naphthalenyloxy-, indenyl-, indolyl-, benzofuranyl-, and benzo[b]thiofuranylcarboxamides of 7,8-(substituted-diamino)-1-oxaspiro[4.5]decanes are useful as analgesic agents. A method of making the compounds, pharmaceutical compositions employing the compounds, and a method of alleviating pain in warm-blooded animals are also disclosed.
Claims
exact text as granted — not AI-modifiedI claim:
1. A compound having the structure ##STR17## wherein n is an integer of from one to six; either of X or Y is oxygen and the other is --CH 2 --; R 1 is selected from ##STR18## where R 4 and R 5 are independently hydrogen, fluorine, chlorine, bromine, nitro, trifluoromethyl, alkyl of from one to six carbon atoms, alkoxy of from one to six carbon atoms, or aryl; ##STR19## where R 6 is hydrogen, fluorine, chlorine, alkyl of from one to six carbon atoms, or aryl; Z is --CH 2 --, --O--, --S--, or --NR 7 -- where R 7 is hydrogen, alkanoyl of from two to six carbon atoms, or alkyl of from one to six carbon atoms; ##STR20## where R 8 and R 9 are independently hydrogen, fluorine, chlorine, bromine , alkyl of from one to six carbon atoms, or alkoxy of from one to four carbon atoms; or ##STR21## where R 8 and R 9 are as defined above; R 2 is methyl and R 3 is hydrogen; alkyl of from one to six carbon atoms,; ##STR22## --CH 2 --CH═CH 2 , --CH 2 C.tbd.CH; ##STR23## where R 10 is alkyl of from one to four carbon atoms; or where R 2 and R 3 when taken together with the nitrogen atom to which they are attached, form a pyrrolidinyl, piperidinyl, or hexahydro-1H-azepinyl ring; and the pharmaceutically acceptable acid addition salts thereof.
2. A compound as defined in claim 1 wherein n is one.
3. A compound as defined in claim 1 wherein R 2 and R 3 taken together with the nitrogen atom to which they are attached form a pyrrolidinyl ring.
4. A compound as defined in claim 1 wherein R 1 is ##STR24## where R 4 and R 5 are as defined therein.
5. A compound as defined by claim 1 wherein ##STR25## where R 6 and Z are as defined therein.
6. A compound as defined by claim 5 wherein Z is --CH 2 --.
7. A compound as defined by claim 5 wherein Z is oxygen.
8. A compound as defined by claim 5 wherein Z is sulfur.
9. A compound as defined by claim 5 wherein Z is --NR 7 -- where R 7 is as defined therein.
10. A compound as defined by claim 1 wherein R 1 is ##STR26## where R 8 and R 9 are as defined therein.
11. A compound as defined by claim 4 having the name N-methyl-N-[7-(methyl-2-propynylamino)-1-oxaspiro[4.5]dec-8-yl]phenoxyacetamide.
12. A compound as defined by claim 7 having the name N-[7-[(cyclopropylmethyl)methylamino]-1-oxaspiro[4.5]dec-8-yl]-N,2-dimethylbenzo[b]furan-3-acetamide.
13. A compound as defined by claim 9 having the name N-methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]-1H-indole-3-acetamide.
14. A compound as defined by claim 4 having the name N-methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]-2-(3-nitrophenoxy)acetamide.
15. A compound as defined by claim 4 having the name N-methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]-2-(3-trifluoromethylphenoxy)acetamide.
16. A compound as defined by claim 7 having the name N-methyl-N-[7[(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]-2-bemzo[b]furanacetamide.
17. A compound as defined by claim 7 having the name N-methyl-N-[7[(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]-3-bemzo[b]furanacetamide.
18. A compound as defined by claim 7 having the name N-methyl-N-[7[(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]-4-bemzo[b]furanacetamide.
19. A compound as defined by claim 6 having the name N-methyl-N-[7-(methyl-2-propenylamino)-1-oxaspiro[4.5]dec-8-yl]-1H-indene-3-acetamide.
20. A compound as defined by claim 4 having the name 2-(4-fluorophenoxy)-N-methyl-N-[7-[methyl-(2-phenylethyl)amino]-1-oxaspiro[4.5]dec-8-yl]acetamide.
21. A compound as defined by claim 4 having the name 2-(3,4-dichlorophenoxy)-N-methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]acetamide.
22. A compound as defined by claim 4 having the name 2-(2,6-dichlorophenoxy)-N-methyl-N-[7-(-1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]acetamide.
23. A compound as defined by claim 4 having the name 2-(3,5-dichlorophenoxy)-N-methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]acetamide.
24. A compound as defined by claim 6 having the name N-methyl-N-[7-(1-pyrrolodinyl)-1-oxaspiro[4.5]dec-8-yl]-3-indeneacetamide.
25. A compound as defined by claim 9 having the name N-[7-(dimethylamino)-1-oxaspiro-[4.5]dec-8-yl]-N-methyl-1H-indole-3-acetamide.
26. A compound as defined by claim 4 having the name 2-(4-fluorophenoxy)-N-methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]acetamide.
27. A compound as defined by claim 10 having the name N-methyl-2-(1-naphthalenyloxy)-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]acetamide.
28. A method of alleviating pain in a warm-blooded animal comprising administering to said animal in need of such treatment an analgesically effective amount of a compound as defined by claim 1 in combination with a pharmaceutically acceptable carrier.
29. A compound as defined by claim 10 having the name N-methyl-N-[7-[methyl[2-(2-thienyl)ethyl]amino]-1-oxaspiro[4.5]dec-8-yl]-2-(1-naphthalenyloxy)acetamide.
30. A pharmaceutical composition useful for treating pain in a warm-blooded animal comprising an analgesically effective amount of a compound as defined by claim 1 in combination with a pharmaceutically acceptable carrier.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.